Program Schedule

41
Antimicrobial Resistance: Novel Agents and Approaches to Gram-positive Infections

Thursday, October 9, 2014: 12:30 PM-2:00 PM
Room: The Pennsylvania Convention Center: IDExpo Hall BC

Learning Objectives:

.

Target Audience: Vaccinologists, Scientists, Researchers, Public health practitioners, Pharmacists, Nurses, Microbiologists, Members-in-training, Medical students and residents, Lab personnel, Investigators, Infectious diseases physicians, Infectious diseases pediatricians, Infection preventionists, Hospital epidemiologists, HIV specialists, HIV clinicians, Health care workers, Fellows, Epidemiologists, Clinicians, Academicians

Tracks: Pediatric ID, Investigative ID, HIV-STD-TB, Global ID, Epidemiology and Infection Control, Adult ID

Presentations:
266
Dalbavancin versus Vancomycin for the treatment of acute bacterial skin and skin structure infections (ABSSSI): a subanalysis from the DISCOVER studies
Sailaja Puttagunta, MD ; Helen Boucher, MD, FIDSA ; George Talbot, MD ; Mark Wilcox, MD ; Michael Dunne, MD
267
Dalbavancin for the treatment of Streptococcal Skin Infections
Sailaja Puttagunta, MD ; Michael Dunne, MD
270
SYN-004, a Class A Beta-Lactamase Therapy for the Prevention of Antibiotic-Induced Disruption of Intestinal Microflora
Michael Kaleko, MD, PhD ; Andrew Bristol, PhD ; Sheila Connelly, PhD ; Pertti Koski, PhD
Posters
  • 270_IDWPOSTER.pdf (340.2 kB)
  • CME Credits:

    ACPE Credits:

    ACPE Number:


    Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

    Sponsoring Societies:

    © 2014, idweek.org. All Rights Reserved.

    Follow IDWeek